Effect of Lithium Therapy on Long COVID Symptoms
Completed · Phase 2 · Has a placebo group
Conditions studied: Long COVID
In brief
This study will assess low-dose lithium's effects on several different symptoms experienced by long COVID patients.
Key facts
- Study ID
- NCT05618587
- Run by
- State University of New York at Buffalo
- People needed
- 52
- Starts
- 2022-11-28
- Expected to finish
- 2023-07-21
- Last updated by the study team
- 2025-03-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University at Buffalo — Williamsville, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.